Our Weekly Newsletter

Celiac disease is an autoimmune condition where the immune system reacts to gluten, a protein found in wheat, barley, and rye. The intestinal lining can become inflamed and damaged, leading to malabsorption and a variety of symptoms. In adults, classic signs include chronic diarrhea, abdominal pain, and unintended weight loss, but many people experience more subtle clues such as fatigue, iron deficiency, infertility, or skin rashes. Because symptoms often overlap with other conditions like irritable bowel syndrome or lactose intolerance, a careful clinical assessment helps determine who should pursue testing. Early diagnosis can prevent complications and improve quality of life, even in cases where symptoms are mild or intermittent.

The decision to test for celiac disease should consider personal and family risk, dietary history, and potential consequences of missed diagnosis. People with a first-degree relative with celiac disease have an elevated lifetime risk and should discuss testing with their clinician. Those with autoimmune thyroid disease, type 1 diabetes, dermatitis herpetiformis, or unexplained iron deficiency anemia also warrant consideration. Importantly, abstaining from gluten before testing can mask an active disease signal, potentially yielding a false negative. If gluten is being continued, the standard initial screen is a blood test measuring specific antibodies. A positive result prompts referral to a specialist for further confirmation and management planning.

The most common noninvasive screening test looks for antibodies against tissue transglutaminase (tTG-IgA). A positive result suggests the body is reacting to gluten, but it is not definitive on its own. People with low IgA levels may have a false negative, so testing often includes total IgA measurement or alternative antibody tests. If tTG-IgA is positive, a gastroenterologist typically orders an endoscopic biopsy to examine the small intestine directly for villous atrophy, which is a hallmark of celiac disease. Some patients, particularly children, may have positive results on a deamidated gliadin peptide test or a combination panel, but biopsy remains the gold standard for confirmation.

The testing approach must consider age, symptom profile, and potential comorbid conditions. In children with growth concerns, persistent diarrhea, or abdominal distension, doctors often proceed with serologic testing promptly. In adults, clinicians weigh the likelihood of celiac disease against other explanations for symptoms before ordering tests. It is essential to maintain dietary gluten during the testing process unless advised otherwise, because removing gluten can reduce antibody levels and obscure results. A negative screen does not always exclude disease if testing is not timed properly relative to symptom onset or if the patient has recently begun a gluten-free diet.

If blood tests indicate possible celiac disease, the next step is usually an esophagogastroduodenoscopy with duodenal biopsy. This procedure allows direct tissue assessment to confirm whether the villi, small fingerlike projections in the intestine, have been damaged. While the biopsy is generally safe, it carries small risks such as bleeding or discomfort, so patients should have a thorough discussion about benefits and alternatives. In pediatrics, doctors sometimes rely more on serology and clinical response, but biopsy remains a definitive test when diagnosis is uncertain. The results guide treatment decisions, including dietary changes and monitoring for nutritional deficiencies.

Interpreting results requires nuance. A positive serology in the presence of compatible symptoms strongly supports celiac disease, but false positives can occur, particularly with autoimmune conditions or certain infections. A negative serology does not completely rule out the disease, especially if the patient has recently limited gluten intake or has very high metabolic rates that affect antibody production. In some cases, additional tests, such as genetic testing for HLA-DQ2 or HLA-DQ8, help determine susceptibility, though these markers are not diagnostic on their own. Clinicians interpret the full picture: test results, clinical presentation, and patient history together.

After a confirmed diagnosis, the cornerstone of management is a strict, lifelong gluten-free diet. This change often leads to symptom improvement, healing of the intestinal lining, and better nutrient absorption. Patients may experience rapid relief in some symptoms, while others take months to normalize. A registered dietitian familiar with celiac disease can tailor meal plans to individual needs, addressing common nutrient gaps such as iron, calcium, vitamin D, and folate. Regular follow-up helps ensure adherence, monitors growth in children, and detects potential inadvertent gluten exposure. It is also helpful to learn how to read food labels and recognize hidden gluten in sauces, processed foods, and cross-contamination risks.

Ongoing monitoring includes periodic symptom reviews, antibody testing, and, in some cases, repeat biopsies to document healing. Some individuals may face persistent symptoms despite adherence to a gluten-free diet, a situation termed non-responsive celiac disease. In such cases, clinicians reassess for other conditions, verify gluten exposure, and consider alternative explanations like lactose intolerance, irritable bowel syndrome, or refractory disease. Managing comorbidities, such as osteoporosis or anemia, is an important part of long-term care, and patients may need supplements or additional therapies. The goal is to maintain nutrient status while enjoying a flexible, sustainable eating pattern.

For those with a close family history but no symptoms, screening decisions should be personalized. Some individuals choose testing to know their genetic risk or to avoid future uncertainties, while others defer unless symptoms emerge. In asymptomatic patients, a clinician may recommend a watchful waiting approach, reserving antibody testing for the appearance of digestive or systemic signs. Education about potential gluten-related triggers and the impact on reproductive health or bone density can help families decide when to test. If a test is negative but suspicion remains high, re-testing later on a renewed basis may be appropriate once dietary patterns are stable.

When you receive results, discuss them with your healthcare provider to understand next steps clearly. A positive test paired with symptoms usually means celiac disease, leading to dietary modification and nutritional surveillance. A positive biopsy confirms the diagnosis and triggers a plan to prevent complications and optimize healing. A negative result can still be meaningful if symptoms persist or new clues arise; in some cases, repeat testing or a second opinion is warranted. Understanding the implications for family members is also important, since relatives may share genetic risk and benefits from screening.

Beyond traditional serology and biopsy, emerging tests and technologies are refining how clinicians approach celiac disease. Researchers are exploring non-invasive imaging methods, alternative biomarkers, and better ways to differentiate celiac disease from gluten sensitivity and other gastrointestinal disorders. These advances aim to shorten diagnostic timelines, reduce the need for invasive procedures, and improve patient comfort. Meanwhile, practical considerations remain central: maintain gluten exposure during testing, interpret results in context, and engage in shared decision-making with your care team. Patients should be proactive—asking questions, seeking reliable nutrition guidance, and tracking symptoms to map real-world responses to therapy.

In summary, testing for celiac disease should be considered when risk factors or symptoms align, and results must be interpreted within the broader clinical picture. A structured approach—accurate history, appropriate serology, and, when indicated, biopsy—offers the best path to diagnosis. With a confirmed diagnosis, a disciplined gluten-free diet and coordinated medical follow-up support recovery, reduce complications, and promote lasting health. By staying informed and partnering with clinicians, patients can navigate this complex condition with confidence and minimize its impact on daily life.